Industry
Galen’s Penthrox Inhaler Secures Expanded UK License for Paediatric Trauma Pain
Northern Ireland-based Galen has received an expanded UK license for its emergency pain relief inhaler, Penthrox (methoxyflurane). The self-administered "green whistle" is now officially approved for use in conscious children aged six and older suffering from trauma-associated pain.
Industry
Navigating Ireland’s Pharma Dependency: Strategies for Policy and Talent in an Uncertain Era
With pharmaceuticals making up 20% of Ireland’s GDP, the nation’s reliance on the industry brings immense economic benefit but notable risks. We explore how Ireland must adapt its policy, manage geopolitical headwinds, and aggressively attract skilled labour to secure its future.
Industry
Egypt, Ireland Explore Industrial Cooperation in Pharmaceuticals, Renewable Energy, and Advanced Technologies
Egypt’s Minister of Industry and Ireland’s Ambassador discuss strategic collaboration across pharmaceuticals, renewable energy, and technology sectors, aiming to leverage Irish expertise for local manufacturing.
Industry
Viewpoint: Why Ireland’s Pharma Sector is Immune to the Global 'Carbon Leakage' Exodus
A new Central Bank of Ireland study reveals that while global manufacturers flee strict climate laws, Ireland's biopharma sector remains stubbornly rooted. Here is what this means for the future of Irish FDI.
Industry
NICE Recommends Libtayo for Advanced Cervical Cancer in England and Wales
Around 90 women with advanced cervical cancer in the UK could be eligible for treatment with Regeneron's immunotherapy Libtayo each year, following a green light from NICE.
Industry
Irish Universities Association Launches Strategy 2026-2030 to Navigate Technological and Global Shifts
The IUA has unveiled its ambitious five-year strategy, built around five core priorities: Advocacy, Alignment, Agility, Access, and Accountability, aimed at securing the future of Ireland's higher education sector.
Industry
Bridging the Gap: How WorkEqual is Empowering Women and Driving Workplace Equity in Ireland
An in-depth look at WorkEqual, its mission to help women (re)enter the Irish workforce, its national advocacy for gender parity, and the new WorkAbility Programme supporting people with disabilities.
Industry
Ireland Tightens Family Reunification Rules: Higher Income Thresholds, Housing Checks and Stricter Relationship Scrutiny
The Irish Department of Justice has overhauled its family reunification framework, raising the income requirement for Irish citizen sponsors to €75,000 over three years, introducing housing sufficiency checks, and imposing a new two-year waiting period for refugees. Here is everything migrants and families in Ireland need to know.
Industry
U.S. Initiates Tariff Probe into Germany’s Pharmaceutical Pricing Policies
The United States has formally launched a trade investigation under Section 301 into Germany’s drug reimbursement practices, citing concerns that domestic price controls unfairly burden American innovation.
Industry
Beyond the Strait: How the US-Iran Peace Deal Will Reshape Ireland’s Pharmaceutical Value Chains in 2026
With the US-Iran peace deal signed and the Strait of Hormuz set to reopen, Ireland's pharmaceutical export sector stands to benefit from stabilized global energy tariffs, normalized maritime trade corridors, and renewed multinational capital inflows.
Industry
Ireland Announces Major Updates to Employment Permit Occupation Lists
A detailed analytical deep-dive into the Irish Government's 2026 updates to Critical Skills and General Employment Permit lists, reviewing quotas, key sectors, and the proposed changes to the 50:50 rule.
Industry
AbbVie Nears $11 Billion Acquisition of Apogee Therapeutics to Bolster Immunology Pipeline
AbbVie is reportedly in advanced negotiations to acquire clinical-stage biotech Apogee Therapeutics for approximately $10.9 billion in cash, aiming to secure the promising long-acting eczema therapy zumilokibart.